Skip to main content
. Author manuscript; available in PMC: 2011 Aug 26.
Published in final edited form as: Clin Cancer Res. 2009 Jan 15;15(2):677–683. doi: 10.1158/1078-0432.CCR-08-1754

Table 3.

Multivariate Cox regression analysis controlling for PSA, Gleason Grade, pathologic stage, surgical margin, age, and race in patients NED after RP. All p values from Wald test.

Variable Time from RP
Time from BM
Hazard ratio (95% CI) p Hazard ratio (95% CI) p
DTC 6.87 (1.03–45.87) 0.047 4.20 (0.79–22.39) 0.09
PSA 1.00 (0.86–1.16) 0.97 1.04 (0.91–1.81) 0.91
Grade
 4–6 1.0 (referent) 1.0 (referent)
 7 4.7 (1.20–18.49) 0.03 4.14 (1.15–14.97) 0.03
 8–10 8.23 (0.58–116.20) 0.12 5.45 (0.39–76.17) 0.21
Stage
 T2 1.0 (referent) 1.0 (referent)
 T3-4 or N+ 2.17 (0.62–7.63) 0.23 2.26 (0.64–7.95) 0.2
Margin (+) 1.6 (0.43–6.0) 0.49 1.89 (0.55–6.52) 0.31
Age
 40–50 1.0 (referent) 1.0 (referent)
 51–60 1.08 (0.21–5.64) 0.93 0.99 (0.18–5.31) 0.99
 >60 1.25 (0.20–7.65) 0.81 0.80 (0.13–5.06) 0.82
Race 2.55 (0.21–31.25) 0.47 0.74 (0.07–7.01) 0.79

Abbreviations: DTC, disseminated tumor cells; PSA, prostate specific antigen